Literature DB >> 21325207

MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop.

Rehan Ahmad1, Hasan Rajabi, Michio Kosugi, Maya Datt Joshi, Maroof Alam, Baldev Vasir, Takeshi Kawano, Surender Kharbanda, Donald Kufe.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is activated in human breast cancer and other malignancies. Mucin 1 (MUC1) is a heterodimeric cell surface glycoprotein that is overexpressed in human carcinomas and, like STAT3, promotes cell survival and induces transformation. We found that in breast cancer cells, the MUC1 carboxyl-terminal receptor subunit (MUC1-C) associates with the gp130-Janus-activated kinase 1 (JAK1)-STAT3 complex. The MUC1-C cytoplasmic domain interacted directly with JAK1 and STAT3, and MUC1-C was necessary for JAK1-mediated STAT3 activation. In turn, MUC1-C and activated STAT3 occupied the promoter of MUC1, and MUC1-C contributed to STAT3-mediated activation of MUC1 transcription. The MUC1-C inhibitor GO-201 blocked the MUC1-C interaction with STAT3, thereby decreasing MUC1-C and STAT3 occupancy on the MUC1 and STAT3 promoters and activation of STAT3 target genes, including MUC1 itself. These findings indicate that MUC1-C promotes STAT3 activation and that MUC1-C and STAT3 function in an autoinductive loop that may play a role in cancer cell survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325207      PMCID: PMC3070357          DOI: 10.1126/scisignal.2001426

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  50 in total

1.  Cell-associated episialin is a complex containing two proteins derived from a common precursor.

Authors:  M J Ligtenberg; L Kruijshaar; F Buijs; M van Meijer; S V Litvinov; J Hilkens
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

2.  Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.

Authors:  Deepak Raina; Rehan Ahmad; Maya Datt Joshi; Li Yin; Zekui Wu; Takeshi Kawano; Baldev Vasir; David Avigan; Surender Kharbanda; Donald Kufe
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

Review 3.  Dominant negative factors in health and disease.

Authors:  Reiner A Veitia
Journal:  J Pathol       Date:  2009-08       Impact factor: 7.996

Review 4.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

5.  The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family.

Authors:  U M Wegenka; C Lütticken; J Buschmann; J Yuan; F Lottspeich; W Müller-Esterl; C Schindler; E Roeb; P C Heinrich; F Horn
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

6.  MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.

Authors:  Rehan Ahmad; Deepak Raina; Vishal Trivedi; Jian Ren; Hasan Rajabi; Surender Kharbanda; Donald Kufe
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

7.  Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.

Authors:  Rehan Ahmad; Deepak Raina; Colin Meyer; Donald Kufe
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.

Authors:  Heehyoung Lee; Andreas Herrmann; Jie-Hui Deng; Maciej Kujawski; Guilian Niu; Zhiwei Li; Steve Forman; Richard Jove; Drew M Pardoll; Hua Yu
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

9.  MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.

Authors:  Takeshi Kawano; Masaki Ito; Deepak Raina; Zekui Wu; Jacalyn Rosenblatt; David Avigan; Richard Stone; Donald Kufe
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

Review 10.  Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

Authors:  Bharat B Aggarwal; Ajaikumar B Kunnumakkara; Kuzhuvelil B Harikumar; Shan R Gupta; Sheeja T Tharakan; Cemile Koca; Sanjit Dey; Bokyung Sung
Journal:  Ann N Y Acad Sci       Date:  2009-08       Impact factor: 5.691

View more
  58 in total

1.  A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.

Authors:  Govind Panchamoorthy; Hala Rehan; Akriti Kharbanda; Rehan Ahmad; Donald Kufe
Journal:  Hybridoma (Larchmt)       Date:  2011-12

2.  MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Michio Kosugi; Maroof Alam; Maya Datt Joshi; Donald Kufe
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

3.  Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.

Authors:  Michal Bar-Natan; Dina Stroopinsky; Katarina Luptakova; Maxwell D Coll; Arie Apel; Hasan Rajabi; Athalia R Pyzer; Kristen Palmer; Michaela R Reagan; Myrna R Nahas; Rebecca Karp Leaf; Salvia Jain; Jon Arnason; Irene M Ghobrial; Kenneth C Anderson; Donald Kufe; Jacalyn Rosenblatt; David Avigan
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

Review 4.  MUC1 and MUC4: switching the emphasis from large to small.

Authors:  Huguette Albrecht; Kermit L Carraway
Journal:  Cancer Biother Radiopharm       Date:  2011-06       Impact factor: 3.099

5.  MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.

Authors:  Suiyang Liu; Li Yin; Dina Stroopinsky; Hasan Rajabi; Alexandre Puissant; Kimberly Stegmaier; David Avigan; Surender Kharbanda; Donald Kufe; Richard Stone
Journal:  Blood       Date:  2013-11-26       Impact factor: 22.113

6.  MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.

Authors:  Maroof Alam; Rehan Ahmad; Hasan Rajabi; Akriti Kharbanda; Donald Kufe
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

7.  MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.

Authors:  H Rajabi; M Alam; H Takahashi; A Kharbanda; M Guha; R Ahmad; D Kufe
Journal:  Oncogene       Date:  2013-04-15       Impact factor: 9.867

8.  Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.

Authors:  Akriti Kharbanda; Hasan Rajabi; Caining Jin; Deepak Raina; Donald Kufe
Journal:  Mol Cancer Res       Date:  2013-03-28       Impact factor: 5.852

9.  Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.

Authors:  Ping Li; Li Ying Xiao; Hong Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.

Authors:  Hasan Rajabi; Masayuki Hiraki; Donald Kufe
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.